SÊMEIA
Paris, FR · Founded 2017 · 70 employees on LinkedIn · 1 known investors
Sêmeia builds MedicWise, a digital medical device for remote patient monitoring that automatically collects, structures, and analyzes health data for patients with chronic conditions. It serves physicians tracking chronic and long-term illness patients in France, with capabilities such as predicting kidney transplant rejection and graft survival.
Founders & leadership
SÊMEIA was founded in 2017 by Mathieu Godart.
MG
Mathieu GodartFounder
Investors · 1
Frequently asked questions
- What does SÊMEIA do?
- Sêmeia builds MedicWise, a digital medical device for remote patient monitoring that automatically collects, structures, and analyzes health data for patients with chronic conditions. It serves physicians tracking chronic and long-term illness patients in France, with capabilities such as predicting kidney transplant rejection and graft survival.
- Who founded SÊMEIA?
- SÊMEIA was founded by Mathieu Godart in 2017.
- Who are SÊMEIA's investors?
- SÊMEIA's investors include Acton Capital.
- Where is SÊMEIA headquartered?
- SÊMEIA is headquartered in Paris, FR.